Cytokinetics (CYTK) Receivables - Net (2016 - 2026)
Cytokinetics (CYTK) posted quarterly Receivables - Net of $6.8 million for Q1 2026, up 239.31% year-over-year from $2.0 million in Q1 2025, and down 61.57% quarter-over-quarter from $17.8 million in Q4 2025.
Cytokinetics (CYTK) Receivables - Net (2016 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Receivables - Net for 11 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 239.31% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (up 239.31% YoY), while the FY2025 annual figure was $17.8 million, up 6.69% from the prior year.
- Receivables - Net fell to $6.8 million in Q1 2026 per CYTK's latest filing, from $17.8 million in the prior quarter.
- Across five years, Receivables - Net topped out at $17.8 million in Q4 2025 and bottomed at $147000.0 in Q4 2022.
- Historically, Receivables - Net has averaged $4.4 million across 5 years, with a median of $2.0 million in 2022.
- Annual changes were most pronounced in 2022 — Receivables - Net plunged 99.72% — and 2024, when it jumped 1197.74%.
- Cytokinetics' Receivables - Net stood at $147000.0 in 2022, then surged by 772.79% to $1.3 million in 2023, then surged by 1197.74% to $16.6 million in 2024, then increased by 6.69% to $17.8 million in 2025, then plunged by 61.57% to $6.8 million in 2026.
- Business Quant data shows CYTK's Receivables - Net at $6.8 million in Q1 2026, $17.8 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.43 Mn |
| Jun 30, 2026 | 24.43 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 16.65 Mn |
| Dec 31, 2024 | 16.65 Mn |
| Sep 30, 2024 | 244,000.00 |
| Sep 30, 2024 | 244,000.00 |
| Mar 31, 2024 | 834,000.00 |
| Mar 31, 2024 | 834,000.00 |
| Dec 31, 2023 | 1.28 Mn |
| Dec 31, 2023 | 1.28 Mn |